118767-92-3 Usage
Uses
Used in Medicinal Chemistry:
Oxazolo[5,4-b]pyridin-2(1H)-one (6CI,9CI) is used as a heterocyclic compound in medicinal chemistry for its potential to interact with biological systems and exhibit various pharmacological activities. Its unique fused ring structure allows for the development of novel pharmaceutical compounds with potential therapeutic applications.
Used in Drug Development:
In the field of drug development, Oxazolo[5,4-b]pyridin-2(1H)-one (6CI,9CI) serves as a promising candidate for the synthesis of new drugs. Its ability to engage with biological systems and display pharmacological properties makes it a valuable component in the creation of innovative therapeutic agents.
Used in Organic Synthesis:
Oxazolo[5,4-b]pyridin-2(1H)-one (6CI,9CI) is utilized as a building block in the synthesis of various organic compounds with diverse properties and applications. Its unique structure and potential reactivity make it a valuable component in the development of new organic materials and compounds for a wide range of industries.
Check Digit Verification of cas no
The CAS Registry Mumber 118767-92-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,7,6 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 118767-92:
(8*1)+(7*1)+(6*8)+(5*7)+(4*6)+(3*7)+(2*9)+(1*2)=163
163 % 10 = 3
So 118767-92-3 is a valid CAS Registry Number.
118767-92-3Relevant academic research and scientific papers
Synthesis and N-Substitution of an Uncommon Heterocyclic System: OxazoloPyridin-2(1H)-One
Flouzat, Christine,Blanchet, Maryline,Guillaumet, Gerald
, p. 4571 - 4574 (2007/10/02)
Oxazolopyridin-2(1H)-one 2 can be obtained in a one-step procedure.Its reactivity towards nucleophiles and alkylation to nitrogen are described. Key words: oxazolopyridin-2(1H)-one; N-substituted oxazolopyridin-2(1H)-ones; triphosgene.
Oxazolopyridine compounds, compositions and use
-
, (2008/06/13)
The invention relates to the analgesic compounds of general formula (I): STR1 in which: R1, R2, R3, R4, A, Z and m are as defined in the description, their isomers, epimers and diastereoisomers, their addition s